Transformation of Daye Peak Total Drop System
Release time:
2020-07-22
Daye Peak Total Descent System Renovation
News from our newspaper 4# July 1 - 10 , Daye Peak Cement Company used the gap before putting into production after overhaul to renovate the total descent system.
The background operating system of Daye Peak General Step-down Station has poor channel and delayed operation due to the aging of communication equipment. The main transformer's up-down gear is not timely, and the capacitor closing and opening do not respond. The instructions for 10kV switch cabinet such as opening and closing are not executed or delayed, and the basic readings in the background, such as duty log and measurement data, are sometimes absent, it seriously affects the safe, stable and orderly operation of power distribution equipment, and also brings great troubles to the personnel on duty. Moreover, according to the service life of the equipment, Daye Peak has been in operation for 11 years and must be upgraded and replaced.
years later due to the impact of the epidemic, equipment procurement and processing of accessories due to logistics restrictions can not be in place in time, after the winning manufacturer and coordination with all parties, with the epidemic relief, finally in 3 29 from Wuhan to the plant. Daye Peak immediately contacted the power supply ground dispatching station and delayed the power outage to 4 July 1 - 2 . Considering the importance of internal communication, the internal communication network was first reformed, the original communication management machine, GPS timing system and 8 relay protection devices were replaced, the background power monitoring and management software was upgraded, the setting value of 10KV relay protection was recalculated and input, and 11 electric meters were newly installed (for data collection of energy management system), after repeated debugging and trial operation, the overall feeling is that the communication channel is unblocked and there is no "blocking" phenomenon. The response to the switch-on and switch-off instructions of the main transformer and the 10KV switch cabinet is timely. After the background upgrade, the desktop data is stable, the report data is true and reliable, and the equipment runs safely and orderly.
After hard work, the renovation was successfully debugged before the kiln was ignited and produced, without affecting the production, delivery and overhaul of finished products. The quality of the renovation project has achieved the expected results. At the same time, Daye Peak will also refer to the later planning plan of Huangshi power transmission network and the requirements of dispatching data collection, replace the original communication management machine according to the specific conditions of the upper substation (axle transformer), and use optical transmission equipment to transmit the information of total reduction, waste heat and safety network to the dispatching. It is planned to overhaul and implement it next year.
After transformation and upgrading, the system communication speed is improved, the data collection time is improved, the information (telemetry, remote signaling, remote control) response efficiency is improved, and the safety and reliability of the communication system are guaranteed. (Zhang Qingyu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31